Low SARS-CoV-2 seroprevalence in the Austrian capital after an early governmental lockdown

被引:13
作者
Breyer, Marie-Kathrin [1 ,2 ,8 ]
Breyer-Kohansal, Robab [1 ,2 ]
Hartl, Sylvia [1 ,2 ,3 ]
Kundi, Michael [4 ]
Weseslindtner, Lukas [5 ]
Stiasny, Karin [5 ]
Puchhammer-Stoeckl, Elisabeth [5 ]
Schrott, Andrea [2 ]
Foedinger, Manuela [3 ,6 ]
Binder, Michael [7 ]
Fiedler, Markus [2 ]
Wouters, Emiel F. M. [2 ]
Burghuber, Otto C. [2 ,3 ]
机构
[1] Clin Penzing, Dept Resp & Crit Care Med, Vienna, Austria
[2] Ludwig Boltzmann Inst Lung Hlth, Vienna, Austria
[3] Sigmund Freud Univ, Fac Med, Vienna, Austria
[4] Med Univ Vienna, Ctr Publ Hlth, Vienna, Austria
[5] Med Univ Vienna, Ctr Virol, Vienna, Austria
[6] Clin Favoriten, Inst Lab Diagnost, Vienna, Austria
[7] Vienna Healthcare Grp, Vienna, Austria
[8] Ludwig Boltzmann Inst Lung Hlth, Austrian LEAD Study, Klink Penzing, Gebaude G,2 Stock,Sanatoriumstr 2, A-1140 Vienna, Austria
关键词
D O I
10.1038/s41598-021-89711-5
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We analyzed SARS-CoV-2 seroprevalence in a large, well-described representative Viennese cohort after an early governmental lockdown with respect to the occurrence of symptoms and household transmission. Participants of the LEAD Study, a population-based cohort study from Vienna, Austria, were invited along with their household members (April 20th to May20th 2020). Sera were analyzed using anti-SARS-CoV-2 immunoassay including a neutralization test as a confirmatory assay. A total of 12,419 individuals participated (5984 LEAD participants; 6435 household members), 163 (1.31%; 59 LEAD cohort members) of whom were SARS-CoV-2 antibody positive. The estimated number of COVID-19 cases projected from our findings by age and sex for Vienna was 21,504 (1.13%). Cumulative number of positively tested cases in Vienna until May 20th 2020 was 3020, hence 7.1 times (95% confidence interval 5.5-9.1) lower than projected. Relative risk (RR) of seropositivity by age was highest for children aged 6-9 years [RR compared to age group 20-49: 1.21 (CI 0.37-4.01)], lowest for >= 65 years [RR 0.47 (CI 0.21-1.03)]. Half of the positive individuals developed no or mild symptoms. In a multivariate analysis, taste and smell disturbances were most strongly related to SARS-CoV-2 positivity. Infection probability within households with one confirmed SARS-CoV-2-specific antibody-positive person was 31%. Although seroprevalence was very low (1.13%) for a central European capital city, due to an early governmental lockdown, SARS-CoV-2 infections were more prevalent than officially reported polymerase chain reaction-positive cases. Of note, seroprevalence was highest in young children. Half of SARS-CoV-2 antibody-positive subjects had no or only mild symptoms. Taste and smell disturbances were most prominent, possibly guiding clinicians in diagnosing SARS-CoV-2 infection.
引用
收藏
页数:9
相关论文
共 25 条
[1]   Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility [J].
Arons, M. M. ;
Hatfield, K. M. ;
Reddy, S. C. ;
Kimball, A. ;
James, A. ;
Jacobs, J. R. ;
Taylor, J. ;
Spicer, K. ;
Bardossy, A. C. ;
Oakley, L. P. ;
Tanwar, S. ;
Dyal, J. W. ;
Harney, J. ;
Chisty, Z. ;
Bell, J. M. ;
Methner, M. ;
Paul, P. ;
Carlson, C. M. ;
McLaughlin, H. P. ;
Thornburg, N. ;
Tong, S. ;
Tamin, A. ;
Tao, Y. ;
Uehara, A. ;
Harcourt, J. ;
Clark, S. ;
Brostrom-Smith, C. ;
Page, L. C. ;
Kay, M. ;
Lewis, J. ;
Montgomery, P. ;
Stone, N. D. ;
Clark, T. A. ;
Honein, M. A. ;
Duchin, J. S. ;
Jernigan, J. A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (22) :2081-2090
[2]  
Beltrán-Corbellini A, 2020, EUR J NEUROL, V27, P1738, DOI 10.1111/ene.14273
[3]   The LEAD (Lung, Heart, Social, Body) Study: Objectives, Methodology, and External Validity of the Population-Based Cohort Study [J].
Breyer-Kohansal, Robab ;
Hartl, Sylvia ;
Burghuber, Otto Chris ;
Urban, Matthias ;
Schrott, Andrea ;
Agusti, Alvar ;
Sigsgaard, Torben ;
Vogelmeier, Claus ;
Wouters, Emiel ;
Studnicka, Michael ;
Breyer, Marie-Kathrin .
JOURNAL OF EPIDEMIOLOGY, 2019, 29 (08) :315-324
[4]   Clinical determinants for fatality of 44,672 patients with COVID-19 [J].
Deng, Guangtong ;
Yin, Mingzhu ;
Chen, Xiang ;
Zeng, Furong .
CRITICAL CARE, 2020, 24 (01)
[5]   SARS-CoV-2 seroprevalence in COVID-19 hotspots [J].
Eckerle, Isabella ;
Meyer, Benjamin .
LANCET, 2020, 396 (10250) :514-515
[6]   Clinical Characteristics of Coronavirus Disease 2019 in China [J].
Guan, W. ;
Ni, Z. ;
Hu, Yu ;
Liang, W. ;
Ou, C. ;
He, J. ;
Liu, L. ;
Shan, H. ;
Lei, C. ;
Hui, D. S. C. ;
Du, B. ;
Li, L. ;
Zeng, G. ;
Yuen, K. -Y. ;
Chen, R. ;
Tang, C. ;
Wang, T. ;
Chen, P. ;
Xiang, J. ;
Li, S. ;
Wang, Jin-lin ;
Liang, Z. ;
Peng, Y. ;
Wei, L. ;
Liu, Y. ;
Hu, Ya-hua ;
Peng, P. ;
Wang, Jian-ming ;
Liu, J. ;
Chen, Z. ;
Li, G. ;
Zheng, Z. ;
Qiu, S. ;
Luo, J. ;
Ye, C. ;
Zhu, S. ;
Zhong, N. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (18) :1708-1720
[7]   Emergence of coronavirus disease 2019 (COVID-19) in Austria [J].
Kreidl, Peter ;
Schmid, Daniela ;
Maritschnik, Sabine ;
Richter, Lukas ;
Borena, Wegene ;
Genger, Jakob-Wendelin ;
Popa, Alexandra ;
Penz, Thomas ;
Bock, Christoph ;
Bergthaler, Andreas ;
Allerberger, Franz .
WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 (21-22) :645-652
[8]   Culture-Competent SARS-CoV-2 in Nasopharynx of Symptomatic Neonates, Children, and Adolescents [J].
L'Huillier, Arnaud G. ;
Torriani, Giulia ;
Pigny, Fiona ;
Kaiser, Laurent ;
Eckerle, Isabella .
EMERGING INFECTIOUS DISEASES, 2020, 26 (10) :2494-2497
[9]   Characteristics of Household Transmission of COVID-19 [J].
Li, Wei ;
Zhang, Bo ;
Lu, Jianhua ;
Liu, Shihua ;
Chang, Zhiqiang ;
Cao, Peng ;
Liu, Xinghua ;
Zhang, Peng ;
Ling, Yan ;
Tao, Kaixiong ;
Chen, Jianying .
CLINICAL INFECTIOUS DISEASES, 2020, 71 (08) :1943-1946
[10]   Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study [J].
Makaronidis, Janine ;
Mok, Jessica ;
Balogun, Nyaladzi ;
Magee, Cormac G. ;
Omar, Rumana Z. ;
Carnemolla, Alisia ;
Batterham, Rachel L. .
PLOS MEDICINE, 2020, 17 (10)